These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Ontogeny of Lagerhans cells and graft versus host disease. Merad M Adv Exp Med Biol; 2005; 560():115-23. PubMed ID: 15932027 [No Abstract] [Full Text] [Related]
65. The effect of an ultraprotective sunscreen on Langerhans cell alteration induced by ultraviolet light in human skin. Edwards EK; Edwards EK; Frank BL; Rosen LB Int J Dermatol; 1986 Jun; 25(5):327-9. PubMed ID: 3487512 [No Abstract] [Full Text] [Related]
66. Effects of chronic sunlight exposure on the immunological function of the human epidermis. Péguet-Navarro J; Viac J; Guéniche A; Rattis FM; Larnier C; Claudy A; Schmitt D Br J Dermatol; 1995 Oct; 133(4):660-1. PubMed ID: 7577608 [No Abstract] [Full Text] [Related]
67. Cracking the code of skin inflammation with CD1a. Amagai M Nat Immunol; 2016 Sep; 17(10):1133-4. PubMed ID: 27648537 [No Abstract] [Full Text] [Related]
68. Topical pimecrolimus inhibits high-dose UVB irradiation-induced epidermal Langerhans cell migration, via regulation of TNF-α and E-cadherin. Yin Z; Xu J; Zhou B; Wu D; Xu Y; Zhang J; Luo D Drug Des Devel Ther; 2014; 8():1817-25. PubMed ID: 25336924 [TBL] [Abstract][Full Text] [Related]
69. Pimecrolimus -- an anti-inflammatory drug targeting the skin. Grassberger M; Steinhoff M; Schneider D; Luger TA Exp Dermatol; 2004 Dec; 13(12):721-30. PubMed ID: 15560755 [TBL] [Abstract][Full Text] [Related]
70. Pimecrolimus in dermatology: atopic dermatitis and beyond. Gisondi P; Ellis CN; Girolomoni G Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622 [TBL] [Abstract][Full Text] [Related]
71. Effects of pimecrolimus versus triamcinolone on Langerhans cells after UV exposure. Martires KJ; Domingo DS; Hsia A; Fu P; Cooper KD; Baron ED Exp Dermatol; 2011 Mar; 20(3):280-2. PubMed ID: 21166722 [TBL] [Abstract][Full Text] [Related]
72. Topical pimecrolimus 1% reverses long-term suberythemal ultraviolet B-induced epidermal Langerhans cell reduction and morphologic changes in mice. Yin Z; Xu J; Lu Y; Luo D J Drugs Dermatol; 2012 Sep; 11(9):e25-7. PubMed ID: 23135668 [TBL] [Abstract][Full Text] [Related]
73. Up-regulation of human epidermal Langerhans' cell B7-1 and B7-2 co-stimulatory molecules in vivo by solar-simulating irradiation. Laihia JK; Jansen CT Eur J Immunol; 1997 Apr; 27(4):984-9. PubMed ID: 9130654 [TBL] [Abstract][Full Text] [Related]
74. Effects of topical pimecrolimus 1% on high-dose ultraviolet B-irradiated epidermal Langerhans cells. Yin Z; Xu J; Zhang Z; Luo D Int Immunopharmacol; 2012 Dec; 14(4):635-40. PubMed ID: 23079131 [TBL] [Abstract][Full Text] [Related]
75. Solar-simulating irradiation of the skin of human subjects in vivo produces Langerhans cell responses distinct from irradiation ex vivo and in vitro. Laihia JK; Jansen CT Exp Dermatol; 2000 Aug; 9(4):240-7. PubMed ID: 10949544 [TBL] [Abstract][Full Text] [Related]
76. Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis. Hoetzenecker W; Ecker R; Kopp T; Stuetz A; Stingl G; Elbe-Bürger A J Allergy Clin Immunol; 2005 Jun; 115(6):1276-83. PubMed ID: 15940147 [TBL] [Abstract][Full Text] [Related]